Control of Onchocerciasis

Advances in Parasitology

Volumn 61, Issue , 2006, Pages 349-394

  Boatin, Boakye A ^a   Richards Jr , Frank O ^b  

^a WORLD HEALTH ORGANIZATION   (Switzerland)

^b CARTER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DIETHYLCARBAMAZINE; DORAMECTIN; DOXYCYCLINE; IVERMECTIN; MOXIDECTIN; PIPERAZINE DERIVATIVE; SURAMIN;

BLINDNESS; COST BENEFIT ANALYSIS; DISEASE CONTROL; DNA PROBE; DRUG EFFICACY; DRUG HALF LIFE; DRUG SAFETY; EDEMA; EYE DISEASE; EYE INJURY; FEVER; FILARIASIS; GEOGRAPHIC DISTRIBUTION; HEADACHE; HEALTH PROGRAM; HUMAN; KIDNEY INJURY; LOA LOA; ONCHOCERCA VOLVULUS; ONCHOCERCIASIS; PARASITE TRANSMISSION; PARASITE VECTOR; PATCH TEST; PRIORITY JOURNAL; PUBLIC HEALTH; RASH; REVIEW; SERODIAGNOSIS; SKIN DISEASE; WOLBACHIA;

AFRICA; AMERICAS; ANIMALS; COMMUNITY HEALTH SERVICES; DRUG RESISTANCE; FILARICIDES; GEOGRAPHY; HUMANS; INSECT CONTROL; INSECT VECTORS; IVERMECTIN; LOIASIS; NATIONAL HEALTH PROGRAMS; ONCHOCERCA VOLVULUS; ONCHOCERCIASIS; POPULATION SURVEILLANCE; SIMULIIDAE;

LOA LOA;

EID: 33646904206     PISSN: 0065308X     EISSN: None     Source Type: Book Series    
DOI: 10.1016/S0065-308X(05)61009-3     Document Type: Review

References (107)

1. Abiose A. Onchocercal eye disease and the impact of Mectizan treatment. Annals of Tropical Medicine and Parasitology 92 supplement 1 (1998) S11-S22
2. Abiose A., Homeida M., Liese B., Molyneux D., and Remme H. Onchocerciasis control strategies. Lancet 356 (2000) 1523-1524
3. Alexander N.D., Cousens S.N., Yahaya H., Abiose A., and Jones B.R. Ivermectin dose assessment without weighing scales. Bulletin of the World Health Organization 71 (1993) 361-366
4. Alley W.S., Oortmarssen G.J., Boatin B.A., Nagelkerke N.J.D., Plaisier A.P., Remme J.H.F., Lazdins J., Borsboom G.J.J.M., and Habbema J.D.F. Macrofilaricides and onchocerciasis control, mathematical modelling of the prospects for elimination. BMC Public Health 1 (2001) 12
5. Amazigo U.O. Detrimental effects of onchocerciasis on marriage age and breast-feeding. Tropical and Geographic Medicine 46 (1994) 322-325
6. Amazigo U.V., Brieger W.R., Katabarwa M., Akogun O., Ntep M., Boatin B., N'doyo J., Noma M., and Sékétéli A. The challenges of community-directed treatment with ivermectin (CDTI) within the African Programme for Onchocerciasis Control (APOC). Annals of Tropical Medicine and Parasitology 96 supplement 1 (2002) S41-S58
7. Anderson J., Fuglsang H., and Marshall T.F.d.C. Studies on onchocerciasis in the United Cameroon Republic III. A four year follow up of six forest and six savanna villages. The incidence of ocular lesions. Transaction of Tropical Medicine and Hygiene 79 (1976) 362-373
8. Ashburn L.L., Burch T.A., and Brady F.J. Pathologic effects of Suramin, hetrazan and arsenamide on adult Onchocerca volvulus. Boletin de la Oficina Sanitaria Panamericana 28 (1949) 1107-1117
9. Awadzi K., Boakye D.A., Edwards G., Opoku N.O., Attah S.K., Osei-Atweneboana M.Y., Lazdins-Helds J.K., Ardrey A.E., Addy E.T., Quartey B.T., Ahmed K., Boatin B.A., and Soumbey-Alley E.W. An investigation of persistent microfilaridermias despite multiple treatments with ivermectin, in two onchocerciasis-endemic foci in Ghana. Annals of Tropical Medicine and Parasitology 98 (2004) 231-24919
10. Awadzi K., Dadzie K.Y., Schulz-Key H., and Haddock D.R.W. The chemotherapy of onchocerciasis. X. Assessment of four single dose treatment regimes of MK-933 (ivermectin) in human onchocerciasis. Annals of Tropical Medicine and Parasitology 79 (1985) 63-78
11. Awadzi K., and Gilles H.M. The chemotherapy of onchocerciasis. III. A comparative study of DEC and Metrifonate. Annals of Tropical Medicine and Parasitology 79 (1980) 199-210
12. Awadzi K., Hero M., Opoku N.O., Addy E.T., Büttner D.W., and Ginger C.D. The chemotherapy of onchocerciasis. XVIII. Aspects of treatment with suramin. Tropical Medicine and Parasitology 46 (1995) 19-26
13. Benton B. Economic impact of onchocerciasis control through the African Programme for Onchocerciasis Control: an overview. Annals of Tropical Medicine and Parasitology 92 supplement 1 (1998) S33-S39
14. Blacklock B.D. The development of Onchocerca volvulus in Simulium damnosum. Annals of Tropical Medicine and Parasitology 20 (1926) 1-48
15. Blanks J., Richards F., Beltran F., Collins R., Alvarez E., Zea Flores G., Bauler B., Cedillos R., Heisler M., Brandling-Bennett D., Baldwin W., Bayona M., Klein R., and Jacox M. The Onchocerciasis Elimination Program of the Americas: a history of partnership. Pan American Journal of Public Health 3 (1998) 367-374
16. Boatin B., Molyneux D.H., Hougard J.-M., Christensen O.W., Alley E.S., Yaméogo L., Sékétéli A., and Dadzie K.Y. Patterns of epidemiology and control of onchocerciasis in West Africa. Journal of Helminthology 71 (1997) 91-101
17. Boatin B.A., Toé L., Alley E.S., Dembélé N., Weis N., and Dadzie K.Y. Diagnostics in onchocerciasis: future challenges. Annals of Tropical Medicine and Parasitology 92 supplement 1 (1998) S41-S45
18. Borsboom G., Boatin B., Nagelkerke N., Agoua H., Akpoboua K., Soumbey-Alley W., Bissan Y., Renz A., Yameogo L., Remme J., and Habbema D. Impact of ivermectin on onchocerciasis transmission: assessing the empirical evidence that repeated ivermectin mass treatments may lead to elimination/eradication in West Africa. Filaria Journal 2 (2003) 8
19. Botto C. Onchocerciasis hyperendemic in the Unturan mountains-an extension of the endemic region in southern Venezuela. Transactions of the Royal Society of Tropical Medicine and Hygiene 91 (1997) 150-152
20. Boussinesq M., Gardon J., Gardon-Wendel N., Kamgno J., Ngoumou P., and Chippaux J.P. Three probable cases of Loa loa encephalopathy following ivermectin treatment for onchocerciasis. American Journal of Tropical Medicine and Hygiene 58 (1998) 461-469
21. Brieger W.R., Awedoba A.K., Eneanya C.I., Hagan M., Ogbuagu K.F., and Okello D.O. The effects of ivermectin on onchocercal skin disease and severe itching: results of a multicentre trial. Tropical Medicine and International Health 3 (1998) 951-961
22. Brown K.R., and Neu D.C. Ivermectin-clinical trials and treatment schedules in onchocerciasis. Acta Leidensia 59 (1990) 169-175
23. ®). Tropical Medicine and International Health 9 supplement 4 (2004) A26-A44
24. Collins R.C., Gonzales-Peralta C., Castro J., Zea-Flores G., Cupp M.S., Richards Jr. F.O., and Cupp E.W. Ivermectin: reduction in prevalence and infection intensity of Onchocerca volvulus following biannual treatment in five Guatemalan communities. American Journal of Tropical Medicine and Hygiene 47 (1992) 156-169
25. Crosskey R.W. The Natural History of Blackflies (1990), Wiley, Chichester, UK
26. Cupp E., Ochoa A., Collins R.C., Ramberg F.R., and Zea-Flores G. The effect of multiple ivermectin treatments on infection of Simulium ochraceum with Onchocerca volvulus. American Journal of Tropical Medicine and Hygiene 40 (1989) 501-506
27. ®) on adult Onchocerca volvulus in Latin America. Journal of Tropical Medicine and Hygiene 71 (2004) 602-607
28. Cupp E.W., Ochoa O., Collins R.C., Cupp M.S., Gonzales-Peralta C., Castro J., and Zea-Flores G. The effects of repetitive community-wide ivermectin treatment on transmission of Onchocerca volvulus in Guatemala. American Journal of Tropical Medicine and Hygiene 43 (1992) 170-179
29. Dadzie K.Y. Control of onchocerciasis: challenges for the future. Annals of Tropical Medicine & Parasitology 29 supplement 1 (1998) S65-S67
30. Dadzie K.Y., Remme J., Baker R.H.A., Rolland A., and Thylefors B. Ocular onchocerciasis and intensity of infection in the community III. West African rain-forest foci of the vector Simulium sanctipauli. Tropical Medicine and Parasitology 41 (1990) 376-382
31. Dadzie K.Y., Remme J., Rolland A., and Thylefors B. Ocular onchocerciasis an intensity of infection in the community: II. West African rain-forest foci of the vector Simulium yahense. Tropical Medicine and Parasitology 40 (1989) 348-354
32. Dadzie Y., Neira M., and Hopkins D. Final report of the conference on the eradicability of onchocerciasis. Filarial Journal 2 (2003) 2
33. Davies J.B. Description of a computer model of forest onchocerciasis transmission and its application to field scenarios of vector control and chemotherapy. Annals of Tropical Medicine and Parasitology 87 (1993) 41-63
34. Davies J.B. Sixty years of onchocerciasis vector control: a chronological summary with comments on eradication, reinvasion and insecticide resistance. Annual Review of Entomology 39 (1994) 23-45
35. Dawood M.S. Field Treatment of Onchocerciasis in the Sudan with Suramin Preparations and Banocide (1978), World Health Organization, Alexandra
36. de C. Bronsvoort B.M., Renz A., Tchakouté V., Tanya V.N., Ekale D., and Trees A.J. Repeated high doses of avermectins cause prolonged sterilisation, but do not kill, onchocerca ochengi adult worms in African cattle. Filaria Journal 4 (2005) 8
37. De Sole G., Remme J., Awadzi K., Accorsi S., Alley E., Ba O., Dadzie K., Giese J., Karam M., and Keita F. Adverse reactions after mass treatment of onchocerciasis with ivermectin. Combined results from eight community trials. Bulletin of the World Health Organization 67 (1989) 707-719
38. Drameh P., Richards F., Derstine P., and Cross C. Ten years of NGO efforts in controlling Onchocerciasis. Trends in Parasitology 18 (2002) 378-380
39. Duke B.O.L. Evidence for macrofilaricidal activity of ivermectin against female Onchocerca volvulus: further analysis of a clinical trial in the Republic of Cameroon indicating two distinct killing mechanisms. Parasitology 130 (2005) 447-458
40. Duke B.O.L., Zea-Flores G., Castro J., Cupp E.W., and Munoz B. Comparison of the effects of a single dose and four monthly doses of ivermectin on Onchocerca volvulus. American Journal of Tropical Medicine and Hygiene 45 (1991) 132-137
41. Emukah E.C., Osuoha E., Miri E.S., Onyenama J., Amazigo U., Obijuru C., Osuji N., Ekeanyanwu J., Amadiegwu S., Korve K., and Richards F. A longitudinal study of impact of repeated mass ivermectin treatment on clinical manifestations of onchocerciasis in Imo State, Nigeria. American Journal of Tropical Medicine and Hygiene 70 (2004) 556-561
42. Gardon J., Gardon-Wendel N., Demanga-Ngangue, Kamgno J., Chippaux J.P., and Boussinesq M. Serious reactions after mass treatment of onchocerciasis with ivermectin in an area endemic for Loa loa infection. Lancet 350 (1997) 18-22
43. Garms, R. and Kipp, W. (2001). Onchocerciasis control in a highly endemic onchocerciasis focus in Kabarole District, Uganda. 129th Annual Meeting of the American Public Health Association.
44. Greene B.M., Taylor H.R., Cupp E.W., Murphy R.P., White A.T., Schulz-key H., D'Anna S.A., Newland H.S., Goldsmith L.P., Auer C., Hanson A.P., Freeman S.V., Reber E.W., and Williams P.N. Comparison of ivermectin and diethylcarbamazine in the treatment of onchocerciasis. New England Journal of Medicine 313 (1985) 133-138
45. Guderian R.H., Anselmi M., Espinel M., Mancero T., Rivadeneira G., Proano R., Calvopina H.M., Vieira J.C., and Cooper P.J. Successful control of onchocerciasis with community-based ivermectin distribution in the Rio Santiago focus in Ecuador. Tropical Medicine and International Health 2 (1997) 982-988
46. Habbema J.D.F., Alley E.S., Plaisier A.P., van Oortmarssen G.J., and Remme J.H.F. Epidemiological modeling for onchocerciasis control. Parasitology Today 8 (1992) 99-103
47. Hagan M. Onchocercal dermatitis: clinical impact. Annals of Tropical Medicine and Parasitology 92 supplement 1 (1998) S85-S96
48. Hall L.R., and Pearlman E. Pathogenesis of onchocercal keratitis (river blindness). Clinical Microbiological Review 12 (1999) 445-453
49. Heukelbach J., and Feldmeier H. Ectoparasites-the underestimated realm. Lancet 363 (2004) 889-891
50. Heukelbach J.B., Wilcke T., Muehlen M., Albrecht S., Sales de Oliveira F.A., Kerr-Pontes L.R.S., Liesenfeld O., and Feldmeier H. Selective mass treatment with ivermectin to control intestinal helminthiases and parasitic skin diseases in a severely affected population. Bulletin of the World Health Organization 82 (2004) 563-571
51. Hoerauf A., Mand S., Adjei O., Fleischer B., and Büttner D.W. Depletion of Wolbachia endobacteria in Onchocerca volvulus by doxycycline and microfilaridermia after ivermectin treatment. Lancet 357 (2001) 1415-1416
52. Hoerauf A., Volkman L., Hamelmann C., Hamelmann C., Adjei O., Autenrieth I.B., Fleischer B., and Büttner D.W. Endosymbiotic bacteria in worms as targets for a novel chemotherapy in filariasis. Lancet 355 (2000) 1242-1243
53. Homeida M.M., Goepp I., Ali M., Hilyer E., and Mackenzie C.D. Medical achievements under civil war conditions. Lancet 354 (1999) 601
54. Hopkins D.R., Richards F., and Katabarwa M. Whither onchocerciasis control in Africa?. American Journal of Tropical Medicine and Hygiene 72 (2005) 1-2
55. Hougard J.-M., Poudiougo P., Guillet P., Back C., Akpoboua L.K.B., and Quillévéré D. Criteria for the selection of larvicides by the Onchocerciasis Control Programme in West Africa. Annals of Tropical Medicine and Parasitology 87 (1993) 435-442
56. Kale O.O. Onchocerciasis: the burden of disease. Annals of Tropical Medicine and Parasitology 92 supplement 1 (1998) S101-S115
57. Katabarwa M.N., Richards F.R., and Ndyomugyenyi R. In rural Ugandan communities the traditional kinship/clan system is vital to the success and sustainment of the African Programme for Onchocerciasis Control. Annals of Tropical Medicine and Parasitology 94 (2000) 485-495
58. Katholi C.R., Toé L., Merriweather A., and Unnasch T.R. Determining the prevalence of Onchocerca volvulus infection in vector populations by PCR screening of black flies. Journal of Infectious Diseases 172 (1995) 1414-1417
59. Kim A., and Benton B. Cost-Benefit Analysis of the Onchocerciasis Control Program (OCP) (1995), World Bank, Washington, DC
60. Lewalen S., and Courtright P. Blindness in Africa: present situation and future needs. British Journal of Ophthalmology 85 (2001) 897-903
61. Maduka E.C., Nweke L.N., Miri E.S., Amazigo U., and Richards F. Missed treatment opportunities in onchocerciasis mass treatment programs for pregnant and breast-feeding women in southeast Nigeria. Annals of Tropical Medicine and Parasitology 98 (2004) 697-702
62. Mazzotti L. Posibilidad de utilizar como medio diagnostico auxiliar en la onchocercosis, las reacciones alérgicas consecutivas a la administración del 'Hetrazan'. Revista de Instituto de Salubridad y Enfermedadas Tropicales 38 (1948) 235-237
63. Meredith S.E.O., Unnasch T.R., Karam M., Piessen W., and Wirth D.F. Cloning and characterization of an Onchocerca volvulus specific DNA sequence. Molecular Biochemical Parasitology 36 (1989) 1-10
64. Miri E.S. Problems and perspectives of managing an onchocerciasis control programme. Annals of Tropical Medicine and Parasitology 92 supplement 1 (1998) S121-S128
65. Molyneux D.H. Onchocerciasis control in West Africa: current status and future of the onchocerciasis control programme. Parasitology Today 11 (1995) 399-402
66. Newland H.S., Kaiser A., and Taylor H.R. The use of diethylcarbamazine cream in the diagnosis of onchocerciasis. Tropical Medicine and Parasitology 38 (1987) 143-144
67. Ngoumou P., Walsh J.F., and Mace J.M. A rapid mapping technique for the prevalence and distribution of onchocerciasis: a Cameroon case study. Annals of Tropical Medicine and Parasitology 88 (1994) 463-474
68. Nutman T.B., Zimmerman P.A., Kubofcik J., and Kostyu D.D. A universally applicable diagnostic approach to filarial and other infections. Parasitology Today 9 (1994) 76-79
69. Onwujekwe O., Chima R., Shu E., and Okwonko P. Community directed treatment with ivermectin in two Nigerian communities: an analysis of first year start-up process, costs and consequences. Health Policy 62 (2002) 31-51
70. Pearlman E., and Hall L.R. Immune mechanisms in Onchocerca volvulus-mediated corneal disease (river blindness). Parasite Immunology 22 (2000) 625-631
71. Plaisier, A.P. (1996). Modeling onchocerciasis transmission and control. Ph.D Thesis, Erasmus University, Rotterdam.
72. Plaisier A.P., Alley E.S., Boatin B.A., Van Oortmarssen G.J., Remme H., De Vlas S.J., Bonneux L., and Habbema J.D. Irreversible effects of ivermectin on adult parasites in onchocerciasis patients in the Onchocerciasis Control Programme in West Africa. Journal of Infectious Diseases 172 (1995) 204-210
73. Plaisier A.P., van Oortmarssen G.J., Habbema J.D., Remme J., and Alley E.S. ONCHOSIM: a model and computer simulation program for the transmission and control of onchocerciasis. Computer Methods and Programs in Biomedicine 31 (1990) 43-50
74. Plaisier A.P., van Oortmarssen G.J., Remme J., Alley E.S., and Habbema J.D. The risk and dynamics of onchocerciasis recrudescence after cessation of vector control. Bulletin of the World Health Organization 9 (1991) 169-178
75. Prod'hon J., Boussinesq M., Fobi G., Prod'hum J.M., Enyong P., Lafluer C., and Quillévéré D. Lutte contre onchocercose par ivermectin; résultats d'une campagne de masse au Nord-Cameroun. Bulletin of the World Health Organization 69 (1991) 443-450
76. Remme J., Baker R.H.A., De Sole G., Dadzie K.Y., Adams M.A., Alley E.S., Avissey H.S.K., and Walsh J.F. A community trial of ivermectin in the onchocerciasis focus of Asubende, Ghana. I. Effect on the microfilarial reservoir and the transmission of Onchocerca volvulus. Tropical Medicine and Parasitology 40 (1989) 367-374
77. Richards F., Boatin B., Sauerbrey M., and Sékétéli A. Control of onchocerciasis today: status and challenges. Trends in Parasitology 17 (2001) 558-563
78. Richards F., Hopkins D., and Cupp E. Commentary: varying programmatic goals and approaches to river blindness. Lancet 255 (2000) 1663-1664
79. Rougemont A., Hien M., Thylefors B., Prost A., and Rolland A. Traitement de l'onchocercose par la Suramin à faibles doses progressive dans les collectivités hyperendémiques d'Afrique occidentale. 2. Résultats cliniques, parasitologiques et opthalmologique en de transmission contrôlée. Bulletin of the World Health Organization 62 (1984) 261-269
80. Rougemont A., Thylefors B., Duncan M., Prost A., and Ranque P.H. Traitement de l'onchocercose par la suramin à faibles doses progressive dans les collectivités hyperendémiques d'Afrique occidentale. 1. Résultats parasitologique et surveillance opthalmologique en zone de transmission non interrompue. Bulletin of the World Health Organization 58 (1980) 917-922
81. Saint André A., Blackwell N.M., Hall L.R., Hoerauf A., Brattig N.W., Volkmann L., Taylor M.J., Ford L., Hise A.G., Jonathan H., Lass J.H., Diaconu E., and Pearlman E. The role of endosymbiotic Wolbachia bacteria in the pathogenesis of river blindness. Science 295 (2002) 1892-1895
82. Shelley A.J. Vector aspects of the epidemiology of onchocerciasis in Latin America. Annual Review of Entomology 33 (1988) 337-366
83. Stingl P., Ross M., Gibson D.W., Ribas J., and Connor D.H. A diagnostic patch test for onchocerciasis using topical diethylcarbamazine. Transactions of the Royal Society of Tropical Medicine and Hygiene 78 (1984) 254-258
84. Taylor H.R., and Green B.M. The status of ivermectin in the treatment of human onchocerciasis. American Journal of Tropical Medicine and Hygiene 41 (1989) 460-466
85. Taylor M.J., Bandi C., and Hoerauf A. Wolbachia bacterial endosymbionts of filarial nematodes. Advances in Parasitology 60 (2005) 247-286
86. Taylor M.J., and Hoerauf A. Wolbachia bacteria of filarial nematodes. Parasitology Today 15 (1999) 437-442
87. Thomson M.C., Obsomer V., Dunne M., Connor S.J., and Molyneux D.H. Satellite mapping of Loa loa prevalence in relation to ivermectin use in west and central Africa. Lancet 356 (2000) 1077-1078
88. Thomson M.C., Obsomer V., Kamgno J., Gardon J., Samuel Wanji S., Takougang I., Enyong P., Remme J.H., Molyneux D.H., and Boussinesq M. Mapping the distribution of Loa loa in Cameroon in support of the African Programme for Onchocerciasis Control. Filaria Journal 3 (2004) 7
89. Thylefors B. Eliminating onchocerciasis as a public HEALTH problem. Tropical Medicine and International Health 9 supplement (2004) A1-A3
90. Thylefors B., Negrel A.D., Pararajasegaram R., and Dadzie K.Y. Global data on blindness. Bulletin of the World Health Organization 73 (1995) 115-121
91. Tielsch J.M., and Beeche A. Impact of ivermectin on illness and disability associated with onchocerciasis. Tropical Medicine and International Health 9 supplement (2004) A45-A56
92. Trees A.J., Graham S.P., Renz A., Bianco A.E., and Tanya V. Onchocerca ochengi infections in cattle as a model for human onchocerciasis: recent developments. Parasitology 120 supplement (2000) S133-S134
93. Wanji S., Tendongfor N., Esum M., Siker S.J., Yundze S.S.J., Taylor M.J., and Enyong P. Combined utilisation of rapid assessment procedures for loiasis (RAPLOA) and onchocerciasis (REA) in rain forest villages of Cameroon. Filaria Journal 4 (2005) 2
94. Waters H.R., Rehwinkel J.A., and Burnham G. Economic evaluation of Mectizan distribution. Tropical Medicine and International Health 9 supplement (2004) A16-A25
95. Weil J., Steel C., Liftis F., Li B.W., Mearns G., Lobos E., and Nutman T.B. A rapid-format antibody card test for diagnosis of onchocerciasis. Journal of Infectious Diseases 182 (2000) 1796-1799
96. Whitworth J.A.G., Gilbert C.E., Mabey D.M., Maude G.H., Morgan D., and Taylor D.W. Effects of repeated doses of ivermectin on ocular onchocerciasis: community-based trial I, Sierra Leone. Lancet ii (1991) 1100-1120
97. Winnen M., Plaisier A.P., Alley E.S., Nagelkerke N.J.D., van Oortmarssen G., Boatin B.A., and Habbema J.D.F. Can ivermectin mass treatments eliminate onchocerciasis in Africa?. Bulletin of the World Health Organization 80 (2002) 384-390
98. World Health Organization (1987). WHO expert committee on onchocerciasis: third report. Technical Report Series No. 752. Geneva: WHO.
99. World Health Organization (1995a). Expert committee on onchocerciasis control. Technical Report Series No. 852. Geneva: WHO.
100. World Health Organization (1995b). The importance of onchocercal skin disease: report of the Pan-African Study Group on onchocercal skin disease. Document TDR/AFR/RP/95. Geneva: WHO.
101. World Health Organization (1997-1998). The importance of onchocercal skin disease; report of the Pan-African study group on onchocercal skin disease. Document TDR/AFR/RP/95.1 18. Geneva: WHO.
102. World Health Organization (2001). Criteria for certification of interruption of transmission/elimination of human onchocerciasis. Document WHO/CDS/CEE/2001.18a. Geneva: WHO.
103. World Health Organization. River Blindness. Weekly Epidemiological Bulletin 77 (2002) 249-256
104. World Health Organization. Onchocerciasis (river blindness). Report from the thirteenth InterAmerican Conference on Onchocerciasis, Cartagena de Indias, Colombia. Weekly Epidemiological Record 79 (2004) 310-312
105. Yaméogo L., Toe L., Hougard J.M., Boatin B.A., and Unnasch T.R. Pool screen polymerase chain reaction for estimating the prevalence of Onchocerca volvulus infection in Simulium damnosum sensu lato: results of a field trial in an area subject to successful vector control. American Journal of Tropical Medicine and Hygiene 60 (1999) 124-128
106. Zea Flores G. Situation of onchocerciasis in the Americas. Acta Leidensia 59 (1990) 59-60
107. Zimmerman P.A., Guderian R.H., Aruajo E., Eslon L., Kubofcik J., and Nutman T.B. Polymerase chain reaction-based diagnosis of Onchocerca volvulus infection: improved detection of patients with onchocerciasis. Journal of Infectious Diseases 169 (1994) 686-689